As we know, MLCK1 plays an important role in many intestinal disorders such as IBD and CAC, and both knockout of MLCK and treatment of experimental mice with highly specific inhibitors cause deficits in intestinal barrier function [31]. Here, MYLK is linked to inflammatory bowel disease.